Which alpha blocker is selective for α1A receptors in the prostate and has minimal effect on vascular α1B receptors, making it the preferred agent for benign prostatic hyperplasia with minimal blood pressure reduction?

Explanation

## Alpha-1 Receptor Selectivity in BPH Management **Key Point:** Tamsulosin is an **uroselective** alpha-1A antagonist that preferentially blocks α1A receptors in the prostate and bladder neck while sparing α1B receptors on vascular smooth muscle. ### Mechanism of Selectivity Tamsulosin achieves uroselective action through: 1. **Structural affinity** — higher binding affinity for α1A vs. α1B subtypes 2. **Tissue distribution** — α1A predominates in prostatic stroma; α1B in blood vessels 3. **Clinical consequence** — symptom relief of lower urinary tract obstruction without orthostatic hypotension ### Comparison of Alpha Blockers | Agent | Receptor Selectivity | Vascular Effects | BPH Response | Hypertension Use | | --- | --- | --- | --- | --- | | **Tamsulosin** | α1A-selective (uroselective) | Minimal | Excellent | Not preferred | | **Alfuzosin** | α1A-selective (uroselective) | Minimal | Excellent | Not preferred | | **Prazosin** | Non-selective α1 | Significant | Good | Yes (antihypertensive) | | **Doxazosin** | Non-selective α1 | Significant | Good | Yes (antihypertensive) | | **Phenoxybenzamine** | Non-selective α1 + α2 | Severe | Poor | Pheochromocytoma only | **High-Yield:** Tamsulosin is the **gold standard first-line agent** for symptomatic BPH because it relieves obstructive symptoms without causing troublesome hypotension or syncope. **Clinical Pearl:** Patients on tamsulosin rarely experience orthostatic hypotension or syncope on standing, unlike non-selective agents such as prazosin or doxazosin, which commonly cause first-dose syncope and ongoing blood pressure reduction. **Mnemonic:** **TAME the Prostate** — **T**amsulosin is **A**lpha-1A selective, **M**inimal vascular effects, **E**xcellent for BPH. [cite:KD Tripathi 8e Ch 12]